Theodore S. Johnson clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
- Minor: Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG Primary completion date changed from estimate of Aug 2, 2026 to Sep 21, 2026
- Minor: Chemo-immunotherapy Using Ibrutinib Plus Indoximod · Pediatric Brain Cancer Study completion pushed from Sep 30, 2028 to Dec 28, 2029
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 1 | |
| Phase 2 | 1 |
Disease areas by active trials
Glioblastoma (2) · Glioma (2)
Get alerts when Theodore S. Johnson's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.